Issues lobbied + lobbyists (5)
MMM — Medicare/Medicaid
Issues related to prior authorization; ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
HCR — Health Issues
Issues relating to implementation of the No Surprises Act
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); SENATE
DEF — Defense
H.R. 3838/S2296 Pharmacy issues related to the National Defense Authorization Act, FY2026 HR. 6400 / S. 4106 - Rx Access, Choice, Cost Equity, and Supply Stability (Rx ACCESS) Act
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
PHA — Pharmacy
S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act; P.L. 119-75 Consolidated Appropriations Act, 2026 (H.R.7148) Issues related to the specialty drug market. H.R. 5582/S. 2355, Patients Deserve Price Tags Act
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
LBR — Labor Issues/Antitrust/Workplace
Issues related to competition in the health care marketplace.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE